ArticleInvestigational new drugs2014

The HSP90 inhibitor ganetespib has chemosensitizer and radiosensitizer activity in colorectal cancer.

Suqin He et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.